Willow Biosciences (CANSF) Stock Price, News & Analysis

Company Overview

Willow Biosciences Inc. is a biotechnology company specializing in the development and commercial production of cannabinoids through precision fermentation. By leveraging proprietary synthetic biology platforms, the company engineers yeast strains capable of producing pharmaceutical-grade cannabinoid compounds without the need for plant cultivation. Its core mission is to offer a scalable and consistent supply of both common and rare cannabinoids to support pharmaceutical, nutraceutical and research applications.

Willow Biosciences’ product portfolio encompasses a range of cannabinoid molecules, including cannabidiol (CBD), tetrahydrocannabinol (THC), cannabigerol (CBG) and other minor cannabinoids that are difficult to source at scale from traditional plant-based extraction. The company offers contract development and manufacturing services, partnering with biopharma and consumer-health companies to accelerate product development and commercialization. Through integrated R&D and process-scale fermentation, Willow aims to ensure high purity, reproducibility and cost efficiency across its offerings.

Founded in 2015 and headquartered in Charlottetown, Prince Edward Island, Willow Biosciences has expanded its operations to include a demonstration-scale fermentation facility in Barcelona, Spain. This transatlantic footprint supports global supply chains and enables the company to meet demand in key markets across North America and Europe. Willow’s leadership team combines expertise in synthetic biology, bioprocess engineering and cannabinoid science, positioning the company as a specialized supplier for innovative health-science applications.

Key Stats

• Today's Range: $0.19 to $0.19
• 50-Day Range: $0.01 to $0.22
• 52-Week Range: $0.00 to $0.10
• Volume: 5,000 shs
• Average Volume: 79,336 shs
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

CANSF Stock Analysis - Frequently Asked Questions

How have CANSF shares performed this year?

Willow Biosciences' stock was trading at $0.0405 at the start of the year. Since then, CANSF stock has increased by 372.6% and is now trading at $0.1914.

How do I buy shares of Willow Biosciences?

Shares of CANSF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

• Today: 7/16/2025
• Next Earnings (Estimated): 8/11/2025

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Medical
• Industry: Drug Manufacturers - Specialty & Generic
• Sub-Industry: N/A
• Current Symbol: OTCMKTS:CANSF
• CIK: N/A
• Web: www.willowbio.com
• Phone: (403) 910-5140
• Fax: N/A
• Employees: 19
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A